Last reviewed · How we verify
Experimental
At a glance
| Generic name | Experimental |
|---|---|
| Also known as | human umbilical cord mesenchymal stem cells (hUC-MSCs) injection, DEPOMEDROL, medical treatment, Atovaquone, SCRT + fruquintinib + sintilimab |
| Sponsor | Xenothera SAS |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Mindfulness-Based Yoga in Schizophrenia (NA)
- Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma (PHASE2)
- Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure (NA)
- The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. (NA)
- A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP) (PHASE2)
- Rosacea and Ivermectin (PHASE2)
- A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases (PHASE3)
- MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |